RemeGen Co. is a biotechnology company that develops antibody-based therapeutic agents, including antibody-drug conjugates, antibody fusion proteins, monoclonal antibodies, and bispecific antibodies. The company offers solutions for autoimmune diseases, oncology, and ophthalmology.
Get AI Stock Predictions Now
Download our app for real-time AI-powered stock predictions on iOS, Android, Windows and macOS
Disclaimer: AI-generated stock predictions are for informational purposes only and do not constitute financial advice. Past performance does not guarantee future results. Always do your own research and consult a qualified financial advisor before making investment decisions. Investing involves risk, including possible loss of principal.